Natera, Inc.
NTRAAPI behind this page
NTRA Q1 2026 request
Playground key active
/api/financials?ticker=NTRA&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 696,644 | 501,830 | +38.8% |
Show Product Lines breakouts |
|||
| Licensing and other revenues | 2,776 | 1,794 | +54.7% |
| Product | 693,868 | 500,036 | +38.8% |
Show Business Segments breakouts |
|||
| Reportable Segment | 696,644 | 501,830 | +38.8% |
Show Geography breakouts |
|||
| Americas, excluding U.S. | 2,402 | 1,692 | +42.0% |
| Asia Pacific and Other | 2,219 | 1,784 | +24.4% |
| EMEA | 6,425 | 6,049 | +6.2% |
| US | 685,598 | 492,305 | +39.3% |
Show Major Customers breakouts |
|||
| Insurance carriers | 658,089 | 472,647 | +39.2% |
| Laboratory partners | 28,817 | 20,832 | +38.3% |
| Patients | 9,738 | 8,351 | +16.6% |
| Cost of Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Licensing and other revenues | 608 | 452 | +34.5% |
| Licensing and other revenues · Reportable Segment | 608 | 452 | +34.5% |
| Product | 245,203 | 184,613 | +32.8% |
| Product · Reportable Segment | 245,203 | 184,613 | +32.8% |
| Research & Development | 210,702 | 129,078 | +63.2% |
| Selling, General & Administrative | 327,938 | 266,864 | +22.9% |
| Amortization Of Intangible Assets | 7.1 | 0.3 | +2266.7% |
Show Business Acquisition breakouts |
|||
| Foresight Diagnostics, Inc. | 5,709 | — | — |
| Total Costs & Expenses | 790,160 | 581,007 | +36.0% |
| Operating Income | -93,516 | -79,177 | -18.1% |
| Interest Expense | -892 | -1,005 | +11.2% |
| Other Non-Operating Income (Expense) | 9,600 | 13,419 | -28.5% |
| Income Before Taxes | -84,808 | -66,763 | -27.0% |
| Income Tax Expense (Benefit) | -283 | -173 | -63.6% |
| Net Income | -85,091 | -66,936 | -27.1% |
Show Equity Components breakouts |
|||
| Retained Earnings | -85,091 | -66,936 | -27.1% |
| Unrealized Gain Or Loss On Available For Sale Securities And Foreign Currency Translation Adjustment | 56 | 147 | -61.9% |
| Comprehensive Income | -85,035 | -66,789 | -27.3% |
| EPS (Basic) | -0.6 | -0.5 | -20.0% |
| EPS (Diluted) | -0.6 | -0.5 | -20.0% |
| Wtd Avg Shares (Basic) | 141,502 | 134,750 | +5.0% |
| Wtd Avg Shares (Diluted) | 141,502 | 134,750 | +5.0% |
| Gross Profit (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 450,833 | 316,765 | +42.3% |
| Other Comprehensive Income | 56 | 147 | -61.9% |
| Provision For Loan Lease And Other Losses | 222 | 195 | +13.8% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,087,932 | 973,768 | +11.7% |
| Accounts Receivable | 417,595 | 318,233 | +31.2% |
| Inventory | 70,721 | 50,367 | +40.4% |
| Prepaid Expenses & Other Current Assets | 75,565 | 56,185 | +34.5% |
| Total Current Assets | 1,651,813 | 1,416,385 | +16.6% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 269,379 | 180,453 | +49.3% |
| Operating Lease Right-of-Use Assets | 133,987 | 94,631 | +41.6% |
| Goodwill | 140,857 | — | — |
| Other Non-Current Assets | 51,000 | 40,897 | +24.7% |
| Total Assets | 2,614,398 | 1,732,366 | +50.9% |
| Intangible Assets | 367,362 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 367,362 | — | — |
| Current Liabilities | |||
| Accounts Payable | 62,397 | 39,240 | +59.0% |
| Employee Related Liabilities Current | 143,810 | 47,086 | +205.4% |
| Business Combination Contingent Consideration Liability Current | 22,350 | — | — |
Show Business Acquisition breakouts |
|||
| Foresight Diagnostics, Inc. | 22.4 | — | — |
| Deferred Revenue (Current) | 36,852 | 20,557 | +79.3% |
| Short Term Borrowings | 80,305 | 80,345 | -0.0% |
Show Debt Instrument breakouts |
|||
| UBS Credit Line | 80.3 | 80.3 | 0.0% |
| Other Liabilities Current | 212,543 | 178,449 | +19.1% |
| Total Current Liabilities | 558,257 | 365,677 | +52.7% |
| Non-Current Liabilities | |||
| Business Combination Contingent Consideration Liability Noncurrent | 103,204 | — | — |
| Deferred Tax And Other Liabilities Noncurrent | 701 | — | — |
| Operating Lease Liabilities | 144,953 | 103,056 | +40.7% |
| Contract With Customer Liability Noncurrent | 16,999 | 16,705 | +1.8% |
| Other Non-Current Liabilities | 16,266 | — | — |
| Total Liabilities | 840,380 | 492,691 | +70.6% |
| Stockholders' Equity | |||
| Common Stock | 14 | 14 | 0.0% |
| Additional Paid In Capital Common Stock | 4,635,319 | 3,874,656 | +19.6% |
| Retained Earnings | -2,861,113 | -2,634,798 | -8.6% |
| Accumulated Other Comprehensive Income | -202 | -197 | -2.5% |
| Total Stockholders' Equity | 1,774,018 | 1,239,675 | +43.1% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -202 | -197 | -2.5% |
| Additional Paid In Capital | 4,635,319 | 3,874,656 | +19.6% |
| Common Stock | 14 | 14 | 0.0% |
| Retained Earnings | -2,861,113 | -2,634,798 | -8.6% |
| Total Liabilities & Equity | 2,614,398 | 1,732,366 | +50.9% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -85,091 | -66,936 | -27.1% |
| Depreciation & Amortization | 14,517 | 9,237 | +57.2% |
| Operating Lease Cost | 5,931 | 4,389 | +35.1% |
| Non Cash Stock Settlement Expense | 1,226 | — | — |
| Stock-Based Compensation | 95,107 | 77,827 | +22.2% |
| Fair Value Adjustment Of Warrants | -166 | -3,235 | +94.9% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 6,120 | — | — |
Show Business Acquisition breakouts |
|||
| Foresight Diagnostics, Inc. | 7.2 | — | — |
| Foreign Currency Transaction Gain Loss Before Tax | 258 | 138 | +87.0% |
| Non Cash Interest Expense | -18 | -17 | -5.9% |
| Noncash Expense Recovery | -596 | -361 | -65.1% |
| Change in Accounts Receivable | -121,067 | -4,068 | -2876.1% |
| Change in Inventory | -2,278 | -5,623 | +59.5% |
| Increase Decrease In Operating Lease Right Of Use Assets | 255 | — | — |
| Change in Prepaid & Other Assets | -17,064 | -9,354 | -82.4% |
| Change in Accounts Payable | 21,880 | 2,379 | +819.7% |
| Increase Decrease In Employee Related Liabilities | 98,233 | 17,035 | +476.7% |
| Increase Decrease In Operating Lease Liability | -5,852 | -4,505 | -29.9% |
| Increase Decrease In Other Accrued Liabilities | 12,105 | 26,866 | -54.9% |
| Change in Deferred Revenue | 11,882 | 671 | +1670.8% |
| Change in Other Liabilities | -920 | — | — |
| Net Cash from Operations | 40,171 | 44,452 | -9.6% |
| Investing Activities | |||
| Capital Expenditures | -22,137 | -21,815 | -1.5% |
| Investment In Related Party | -10,000 | — | — |
| Net Cash from Investing | -32,137 | -16,815 | -91.1% |
| Purchases Of Property And Equipment In Accounts Payable And Accruals | 18,216 | 4,223 | +331.4% |
| Acquisition Of Warrants And Warrants Receivable | 7,162 | — | — |
| Issuance Of Common Stock For Business Acquisition | -213 | — | — |
| Stock Issued1 | 774 | — | — |
| Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition | 47,026 | 32,063 | +46.7% |
Show Equity Components breakouts |
|||
| Additional Paid In Capital | 47,026 | 32,063 | +46.7% |
| Stock Based Compensation Included In Capitalized Software Development Costs | 391 | 608 | -35.7% |
| Financing Activities | |||
| Proceeds From Stock Options Exercised | 3,863 | 544 | +610.1% |
| Payments Of Stock Issuance Costs | -105 | — | — |
| Net Cash from Financing | 3,758 | 544 | +590.8% |
| Supplemental | |||
| Interest Paid | 889 | 1,005 | -11.5% |
| Other Cash Flow | |||
| Net Change in Cash | 11,792 | 28,181 | -58.2% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.